Biochemistry
GENOMICA S.A.U is the leading Spanish Company in Molecular Diagnostics. Founded in 1990, it is located in the city of Madrid and is 100% owned by Zeltia.
It is their mission to improve the present molecular diagnostics tests in the area of life sciences through quality and automation.
Genomica's main objective is to become the market leader in genomics applications, and to extend their activities in the area of Molecular Diagnostics in Europe by means of the design, development and commercialization of new diagnostic applications with their innovative in vitro diagnosis platform, CLINICAL ARRAYS.
CLINICAL ARRAYS MetaBone is the microarray system for identification of gene polymorphisms. Targeted polymorphisms by this kit have been related with high predisposition to suffer endocrine system pathologies, rheumatological alterations and osteophatologies.
Click here for further information on MetaBone.
| PRODUCT | CODE | UNIT |
| Clinical Arrays MetaBone Extraction/Purification & Amplification | AT-0506-024 or -048 | 24 or 48 tests |
| Clinical Arrays MetaBone Genotyping | AT-0606-024 or -048 | 24 or 48 tests |